Key points are not available for this paper at this time.
Our study suggests a new role for MDSCs in patients with HCC in disarming the innate immune system and further contributing to the immune suppressor network in these patients. These findings have important implications when designing immunotherapy protocols.
Hoechst et al. (Fri,) studied this question.